Genetic evidence for a new type of major histocompatibility complex class II combined immunodeficiency characterized by a dyscoordinate regulation of HLA-D alpha and beta chains

doi:10.1084/jem.183.3.1063

This Article

	Full Text (PDF, 1052K)
	Alert me when this article is cited
	Citation Map

Services

	Email this article
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new content in the JEM
	Download to citation manager

Citing Articles

	Citing Articles via HighWire
	Citing Articles via CrossRef
	Citing Articles via Google Scholar

Google Scholar

	Articles by Douhan, J.
	Articles by Glimcher, L. H.
	Search for Related Content

PubMed

	PubMed Citation
	Articles by Douhan, J., 3rd
	Articles by Glimcher, L. H.


Social Bookmarking

	What's this?

ARTICLES

Genetic evidence for a new type of major histocompatibility complex class II combined immunodeficiency characterized by a dyscoordinate regulation of HLA-D alpha and beta chains

J Douhan 3rd, I Hauber, MM Eibl and LH Glimcher
Department of Cancer Biology, Harvard School of Public Health, Boston, Massachusetts 02115, USA.

Major histocompatibility complex (MHC) class II combined immunodeficiency (CID), also known as type II bare lymphocyte syndrome, is an autosomal recessive genetic disorder characterized by the complete lack of expression of MHC class II antigens. The defect results from a coordinated lack of transcription of all class II genes. Cell fusion studies using many patient- and experimentally derived class II-negative cell lines have identified four distinct genetic complementation groups. In this report, we present genetic evidence that cell lines derived from two newly described MHC class II-deficient patients, KER and KEN, represent a fifth complementation group. In addition, the KER and KEN cell lines display a unique pattern of dyscoordinate regulation of their MHC class II genes, which is reflected in a new phenotype of in vivo promoter occupancy as revealed by in vivo genomic footprinting. These data point to a new defect that can result in the MHC class II-deficient phenotype.
Add to CiteULike CiteULike Add to Complore Complore Add to Connotea Connotea Add to Del.icio.us Del.icio.us Add to Digg Digg Add to Reddit Reddit Add to Technorati Technorati What's this?

This article has been cited by other articles:

Shao, L., Sperber, K. (2002). Impaired Regulation of HLA-DR Expression in Human Immunodeficiency Virus-Infected Monocytes. CVI 9: 739-746 [Full Text]
Rakoff-Nahoum, S., Chen, H., Kraus, T., George, I., Oei, E., Tyorkin, M., Salik, E., Beuria, P., Sperber, K. (2001). Regulation of Class II Expression in Monocytic Cells after HIV-1 Infection. J. Immunol. 167: 2331-2342 [Abstract] [Full Text]
Kanazawa, S., Peterlin, B. M. (2001). Combinations of dominant-negative class II transactivator, p300 or CDK9 proteins block the expression of MHC II genes. Int Immunol 13: 951-958 [Abstract] [Full Text]
Lennon-Dumenil, A.-M., Barbouche, M.-R., Vedrenne, J., Prod'Homme, T., Bejaoui, M., Ghariani, S., Charron, D., Fellous, M., Dellagi, K., Alcaide-Loridan, C. (2001). Uncoordinated HLA-D Gene Expression in a RFXANK-Defective Patient with MHC Class II Deficiency. J. Immunol. 166: 5681-5687 [Abstract] [Full Text]
Nekrep, N., Jabrane-Ferrat, N., Peterlin, B. M. (2000). Mutations in the Bare Lymphocyte Syndrome Define Critical Steps in the Assembly of the Regulatory Factor X Complex. Mol. Cell. Biol. 20: 4455-4461 [Abstract] [Full Text]
Peijnenburg, A., Van Eggermond, M. J. C. A., Gobin, S. J. P., Van den Berg, R., Godthelp, B. C., Vossen, J. M. J. J., Van den Elsen, P. J. (1999). Discoordinate Expression of Invariant Chain and MHC Class II Genes in Class II Transactivator-Transfected Fibroblasts Defective for RFX5. J. Immunol. 163: 794-801 [Abstract] [Full Text]
Scholl, T., Mahanta, S. K., Strominger, J. L. (1997). Specific complex formation between the type II bare lymphocyte syndrome-associated transactivators CIITA�and�RFX5. Proc. Natl. Acad. Sci. USA 94: 6330-6334 [Abstract] [Full Text]